FDA 483 - AbbVie Inc. - January 31, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Abbvie, Inc. in North Chicago, IL was inspected and received a Form 483 with five observations. The inspection revealed significant issues with laboratory controls, including inadequate investigations into OOS/OOT results and untimely confirmatory testing using expired samples. Additionally, the firm failed to establish scientifically sound specifications, maintain proper quality control unit responsibilities, control cross-contamination, and follow written procedures for equipment cleaning and maintenance.
ID · 51b48e1e-9723-4387-b252-4cc5015026fd